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ABSTRACT 
Background 
The often excellent outcome of total hip arthroplasty (THA) is sometimes compromised 
by prosthesis related complications. There is an ongoing debate regarding the effect of 
surgical approach on prosthesis related complications and patient reported outcome. 
The incidence of periprosthetic joint infection (PJI) following THA in Sweden is 
unknown as well as the completeness of the Swedish Hip Arthroplasty Register 
(SHAR) to record reoperations due to infection.  
Methods 
Study 1 and 2 were solely based on data from the SHAR. In study 1, the risk of revision 
due to infection, dislocation and loosening of the prosthesis was compared between the 
posterior and the direct lateral approach for the most commonly used cemented THAs. 
Relative risks were calculated with a Cox regression analysis with respect to known 
confounders. In study 2, Patient Reported Outcome Measures (PROMs) were compared 
between patients that had received a THA for osteoarthritis by either the posterior or 
direct lateral approach. The postoperative pain, satisfaction and health related quality of 
life were compared by Chi2-test, T-test and multivariate regression analysis. 
In study 3 and 4 a large cohort of patients that had undergone primary THA were 
selected from the SHAR and their antibiotic consumption was extracted from the 
Swedish Prescribed Drugs Register (SPDR). For patients with ≥28 days of antibiotic 
treatment within 2 years after the surgery a medical records review was conducted. 
From this survey the cumulative incidence of early and delayed PJI was calculated. The 
number of reoperated THAs due to infection were compared with the SHAR 
reoperation database determining the completeness of the register. In Study 5, PJI-cases 
were compared to matched controls regarding known and suspected risk factors from 
the SHAR and the National Patient Register and analyzed by multivariate regression 
analysis. 
Results 
The posterior approach lead to superior PROM values for patients with OA and lead to 
less aseptic loosening but increased risk of dislocation in some of the investigated all 
cemented THAs. The cumulative incidence of early and delayed PJIs in Sweden for the 
study period was 0.9 % and the trend was slightly increasing. The registration 
completeness of reoperations due to infection in the SHAR was 67 %. Patient 
comorbidity had more influence than surgical or environmental factors on PJI risk.  
Discussion 
The discussion regarding the advantages of different surgical approaches in THA is not 
ended by these studies, but it seems that the surgical approach has influence on the 
outcome. The surgical approach should therefore perhaps be a part of the preoperative 
planning just as the method of fixation and implant and related to both patient factors 
and the reason for the THA. 
In order to reduce the infection incidence it is important to define the magnitude of the 
incidence. This study presents a novel approach to incidence estimation and evaluates 
the SHAR reoperation database which has been the most commonly used measure of 
infections after THA in Sweden. As patient comorbidity seems to be the most 
important factor on a population level it will be difficult to further decrease the 
incidence.  
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1 BACKGROUND 
1.1 THE HISTORY OF TOTAL HIP ARTHROPLASTY 
The first attempts to surgically treat painful osteoarthritis were made in the beginning 
of the 19th century. The available method was interpositioning of various soft tissues in 
the joint but did not have long lasting effect (1). In 1938 Smith-Pedersen described 
interpositioning of a vitallium cup covering the femoral head which introduced the hip 
arthroplasty (2). The Judet brothers introduced the hip replacement arthroplasty by 
replacing the femoral head with an artificial head made by acrylic resin. It was however 
Wiles that introduced the first total hip arthroplasty (THA) (3). Although many doctors 
tried to refine the method and materials over the early period it was not until the 1960s 
that Sir John Charnley introduced the low friction arthroplasty that revolutionized the 
principles of hip replacement (4). The most important contributions were the principle 
of rigid fixation of the prosthesis to the bone, the replacement of both joint surfaces and 
the use of low friction polyethylene. The principles made by Charnley are still highly 
relevant today. Over the years many attempts have been made to refine the many 
aspects of hip replacement including prosthesis material, size and bearing surfaces, 
fixation methods, surgical approaches and more. Nowadays the result of a THA to 
increase function and reduce pain in different hip injuries and disorders is in general 
very good and the intervention has been called “the operation of the century” (1).  
 
Some of the complications following a THA are not evident until after some years after 
the primary operation. Together with decreasing complication incidence, the evolution 
of arthroplasty design has been dependent on long term follow up in national joint 
replacement registries. By using the large populations of these registries statistic 
comparisons between implant designs, fixation methods etc. have been possible and 
this is an important factor that has contributed to today’s long survivorship of the 
modern THA (5).  
 
Today more than 1 million procedures are undertaken each year worldwide (5). In an 
ageing population with higher demands on physical activity, treatment with THA for 
osteoarthritis will increase annually (6, 7). As a result of increasing implant survival, 
primary THA is a more attractive alternative in a younger age which also contributes to 
an increasing procedure incidence (8). Thus despite the good results today there is still 
an incentive to continuously improve the outcome of THA. 
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1.2 SURGICAL APPROACHES 
There are many surgical approaches described for a THA. The most common 
approaches in Sweden 2012 were the posterior approach (52 %) followed by the direct 
lateral in side position (42 %) and direct lateral in supine position (5 %) (9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
Distribution of surgical 
approaches in primary 
THA in Sweden (from 
the Swedish Hip 
Arthroplasty Register -  
annual report 2012) 
 
Recent years the use of the direct lateral approach without trochanteric osteotomy has 
increased on behalf of the posterior approach in Sweden. One reason may be reports of 
increasing dislocation rates following THA due to hip fracture operated in the posterior 
approach (10). Another reason may be that if the orthopedic surgeon operates without 
an assistant, which seems to become more frequent, the leg is easier to hold for the 
nurse when the direct lateral approach is used. The potential effect on the overall 
outcome in terms of risk of revision and Patient Reported Outcome (PRO) due to this 
development is however unclear. 
 
A meta-analysis of clinical trials published 2006 found no convincing evidence 
supporting either the posterior or direct lateral approach as superior for THA for 
osteoarthritis (11), taking complications into account. 
 
  
VIKTOR LINDGREN                                                                                                                                                        3   
 
 
 
1.2.1 The posterior approach 
The posterior approach was introduced by Moore in 1957 (12) and is performed with 
the patient in a side position. The incision runs slightly posterior to the greater 
trochanter and curves posterior in line with the fibers of the greater gluteus muscle. The 
fascia is incised and the fibers of the greater gluteus separated bluntly. This exposes the 
short external rotators (musculus gemellus sup & inf, musculus obturatorius and 
musculus piriformis) which are cut close to their insertion on the femur. The hip 
capsule is then incised and the hip joint is exposed and dislocated dorsally by flection 
and internal rotation of the hip, with the foot of the patient facing upwards. The collum 
femoris is cut and is along with the acetabulum prepared for the implant. When the 
implant is in position the external rotators are sometimes reattached and the fascia of 
the greater gluteus muscle, subcutaneous tissues and skin are closed separately.  
 
 
 
 
Figure 2. The posterior approach, prior to THA (Published with permission from evertsmoth.com) 
 
The posterior approach give good access to the femur which may facilitate stem 
positioning. This may decrease the risk of malalignment and in turn a poor cement 
mantle, which could cause loosening (13). A hip joint is in its most extreme position by 
internal rotation and flection. As the posterior approach violates the posterior capsule 
and muscles this approach has been associated with postoperative instability and 
dislocation (14, 15).  
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1.2.2 The direct lateral approach 
The direct lateral approach without trochanteric osteotomy can either be performed in 
supine position (as described by Hardinge (16)) or in a side position (as described by 
Gammer (17)). The skin and fascia are incised over and in line with the greater 
trochanter. The anterior part of the gluteus medius tendon is together with the anterior 
part of the vastus lateralis muscle (often along with its bony insertion) separated from 
the greater trochanter and reflected medially while the posterior parts of the muscles are 
left intact. The anterior part of the hip capsule is exposed and incised and the hip joint 
is dislocated anteriorly by external rotation, flection and adduction with the patient’s 
foot pointing downwards (in case of operating in supine position – crossing the other 
leg). The collum femoris is cut and prepared along with the acetabulum. After the 
implant is in position the gluteus medius and vastus lateralis muscles are reattached to 
the trochanter and the fascia, subcutaneous tissues and skin are closed separately. 
 
 
 
 
Figure 3. The direct lateral approach prior to THA (Published with permission from evertsmith.com) 
 
The direct lateral approach spares the posterior stabilizing tissues but instead interferes 
with the abductor muscles which in case of non-healing or damage to its innervation 
can result in postoperative abductor weakness, limb and lateral hip pain. Patients 
operated with a THA by the direct lateral approach has been found to suffer higher risk 
of postoperative limp (18, 19). The direct lateral approach offers a good exposure of the 
acetabulum but can sometimes lead to an inferior access to the femur compared to the 
posterior approach.  
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1.3 COMPLICATIONS FOLLOWING TOTAL HIP ARTHROPLASTY 
Complications after THA are rare. There are known medical complications such as 
deep vein thrombosis, pulmonary embolism, pneumonia, myocardial infarction and 
heart failure etc. (20, 21). The postoperative mortality is however low, less than 2 % 
within 3 months (22), especially in elective surgery. This thesis however only deals 
with complications related to the prosthesis. With modern implants >95 % of the 
implants remain unrevised at 15 years follow-up. As complications are rare and often 
occur late they are best determined by observational studies compared to randomized 
trials (23). 
 
1.3.1 Aseptic loosening 
The most common reason for revision of the total hip arthroplasty is loosening of the 
implant (24). Loosening is often discovered when a patient returns with complaints of a 
new pain from a previously replaced hip. It is a result of osteolysis (bone resorption) 
around the implant mediated by osteoclasts. Loosening is related to wear, inferior 
implant design and material and the patient’s activity level (25). Malpositioning of the 
implant has been found to increase wear and thereby implant loosening (26). Loosening 
is often painful and can untreated lead to greater risk of periprosthetic fracture and 
dislocation. If the patient is healthy enough to withstand further surgery the prosthesis 
is therefore often revised.  
 
 
Figure 4. Left: Direct postoperative radiograph of cemented total hip arthroplasty.  
Right: Radiograph of the same hip replacement, showing signs of loosening of femoral stem and 
acetabular cup (arrows).  
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1.3.2 Dislocation 
Dislocation of the prosthesis is an early (often within the first year) complication after 
THA, although it sometimes occurs several years after the primary operation secondary 
to trauma or wear of the acetabular cup that increase instability. The dislocation is most 
often posterior when the hip is in flexion and internal rotation, but can also be anterior 
by external rotation and extension of the hip. It is often very painful and is in its acute 
phase often treated with closed reduction with or without general anesthesia. If it is 
impossible to keep the prosthesis reduced, if the dislocation reoccurs or if the implant is 
loose open reduction with revision of the prosthesis is often inevitable if the patient is 
fit enough to undergo open surgery. 
Most studies show an association between the posterior approach and an increasing risk 
of dislocation especially in combination with smaller head sizes (15, 27). The risk of 
dislocation however also depends on the reattachment of the posterior capsule and 
external rotators (28). Factors influencing risk of dislocation can be divided into groups 
referring to implant (1), operation (2), and patient characteristics (3). Important implant 
factors include head size, head to neck ratio (influencing impingement risk) and cup 
design (29). Operative factors include surgical experience, surgical approach, soft tissue 
treatment/reattachment and implant positioning (30). The most important patient 
characteristic is hip diagnosis (for example fracture compared to OA) (31), but alcohol 
abuse and/or postoperative confusion has also been described as risk factors (32).  
 
 
 
Figure 5. Radiograph of dislocated total hip arthroplasty (left) and after reduction (right) 
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1.3.3 Infection  
The third most frequent complication following THA is periprosthetic joint infection 
(PJI) (24). Commonly it leads to a great suffering to the patient, requires large 
resources of the health care and is associated with high cost to society, especially if 
affecting patients of working age (33-36). Different treatment algorithms have been 
proposed based on experience. If diagnosed early and treated aggressively with 
debridement and irrigation it may be possible to retain the implant. If discovered late, 
one- or two-stage exchange or resection is often needed (37-39) due to biofilm 
formation on the prosthesis protecting the bacteria from antibiotic exposure. Regardless 
of the surgical intervention patients become dependent on antibiotics over a long period 
of time (40, 41). In the literature the incidence of deep infection following primary 
THA ranges from 0.2 up to 1.6 % depending on follow-up time and the methodology of 
the study (42, 43). Some studies have reported increasing risk of revision due to 
infection after THA (44, 45), but the reasons for this are unclear. This could very well 
reflect an increasing risk of infections, possibly due to that an older and medically more 
fragile population is subject for a primary THA. It could however just as well be the 
result of better diagnostics and more active revision policy or that the reporting to 
arthroplasty registries has improved. Concerns have been raised by Jämsen et al 
regarding the validity of recordings of revision due to infection in the Finnish 
Arthroplasty Register, and there is reason to believe that the same might apply to other 
registries as well (46).  
 
The diagnosis of postoperative periprosthetic infection can be defined as early 
(diagnosed within 3 months), delayed (diagnosed between 3 months to 24 months) or 
late (diagnosed after more than 24 months after the primary procedure) (40). The early 
and delayed infections are often considered to be caused by peri- or intraoperative 
contamination. Whether the infection is diagnosed before or after 3 months may depend 
on the aggressiveness of the bacteria (40). Coagulase Negative Staphylococcus (CNS) 
and Staphylococcus Aureus (SA) are the most common isolated infecting 
microorganisms from perioperative cultures (47). There have been reports of increasing 
antibiotic resistant bacteria such as Methicillin-Resistant Staphylococcus Aureus 
(MRSA) and Methicillin-Resistant Staphylococcus Epidermidis (MRSE) which in the 
future will probably be an increasing clinical challenge (48).  
 
Preventive measures should therefore perhaps be able to decrease the early and delayed 
infections but many factors, including both patient and surgical factors, contribute to 
the risk of developing a PJI which make this work difficult (49, 50). Obesity has in 
many studies been shown to increase the risk of infection (22, 51-53). Patient 
comorbidity described as an elevated Charlson index score (54) or ASA-score ≥3 (53, 
55) are also known patient-related risk factors for the development of PJI. Surgical 
factors predisposing for infection includes fixation without antibiotic loaded cement 
(56), bilateral surgery (52, 53) and long duration of surgery (55). Other factors 
described in the literature possibly associated with increased risk of infection includes 
absence of laminar air flow in the operating theatre (57) and bleeding as well as blood 
transfusion (52). It has been found that the incidence differs between clinics and it has 
been stated that there might be other factors that can influence the risk of infection (55, 
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58). Historically many parallel interventions has been successful in decreasing the 
infection burden after THA, which in the early days were as large as 9 % (59).  
 
In Sweden a multi professional initiative called PRISS (Prosthesis Related Infections 
Should be Stopped) was started in 2008 which objective was to reduce the incidence of 
infections by 50 %. The true incidence was however unknown. By 2013 the 
recommendations from this initiative were fully adopted by all orthopedic units in 
Sweden performing joint replacement surgery.  
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1.4 PATIENT REPORTED OUTCOME 
Patient reported outcome is probably the most important parameter when evaluating the 
effect of a surgical procedure which indication is to restore function and relieve pain. It 
is therefore natural that studies evaluating PRO after orthopedic surgery has increased 
over the years. Patient reported outcome measures (PROMs) are often divided into 
generic instruments evaluating Health Related Quality of Life (HRQoL) and disease 
specific instruments. Commonly used generic PROM instruments in evaluation of THA 
include Short Form 36 (SF-36) and EuroQol 5 dimensions (EQ-5D). Disease specific 
instruments often used for evaluating the effect of THA are West Ontario and 
McMasters Universities Osteoarthritis index (WOMAC) and Oxford Hip Score (60). 
 
Many factors influence the PRO after THA. First of all the preoperative function and 
pain are important parameters. Naturally the degree of change depends on the 
preoperative function – a low preoperative function can generate a lager increase than a 
good preoperative function. But even though the change is larger, a low function group 
might not reach as good postoperative scores as a group with better preoperative 
function. Thus both the degree of change and the final outcome, in other words – both 
the journey and the final destination - is important. 
 
Previous studies have also shown that male gender, old age, Charnley category C (see 
chapter 1.5.2.3.2), preoperative anxiety/depression and low education level all 
influence the postoperative outcome negatively (61-67). Prosthesis related 
complications are also known to negatively affect the PROMs in terms of pain and 
function (68, 69). It is also possible that both the patient’s and surgeon’s expectation of 
the procedure affect the patient’s postoperative satisfaction (70, 71).  
 
A few studies have reported superior disease specific PROMs after the posterior 
approach compared to the direct lateral approach in a short follow up (68, 69), but 
according to one study this difference seems to disappear with time (72). It is however 
unclear if the surgical approach affects the generic HRQoL measurement EQ-5D, 
postoperative pain reduction and patient satisfaction and whether such an effect, if 
present, persist over time. 
 
In clinical follow-up studies the reported dissatisfaction after a THA is around 10 % 
(65, 73, 74). There are many possible reasons to this. Patients suffering from a 
complication report worse outcome compared to the patients spared from a 
complication (68, 69) which could affect the postoperative satisfaction. The 
preoperative expectation of the procedure is also likely to play a role and it is therefore 
important that the doctor informs the patient of the expected result of the THA. 
Although failure to improve after the procedure cannot be equated with a complication 
the result can be equally important.  
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1.5 SWEDISH NATIONAL QUALITY AND HEALTH-CARE REGISTERS 
1.5.1 The personal registration number 
Epidemiologic research on populations by registry data has been very successful in 
Sweden. This is above all due to the introduction of the personal registration number in 
1947 and to the liberal use of it in health registries. The personal registration number is 
a unique 10 digit long number. The first 6 digits contain the birth date (year, month and 
day). A hyphen separates this with the serial number of 3 digits where the third digit 
specifies the gender, an odd number indicates male gender and an even number 
indicates female gender. The last tenth digit is a control number. The use of the 
personal registration number introduces a possibility to match different registries that 
can complement each other in terms of data.  
 
1.5.2 The Swedish Hip Arthroplasty Register 
Quality registries in Sweden has a long history. The Swedish Hip Arthroplasty Register 
(SHAR) was the second national quality register started in 1979 in order to improve the 
results of THA by studying complications. Today all units performing total hip 
arthroplasty in Sweden voluntary participate (75), thus the coverage is 100 %.  
 
1.5.2.1 Primary THA 
About 16 000 primary THAs are recorded each year and the primary database is 
continuously automatically validated by matching with the National Patient Register 
(NPR). By the year 2012 the overall completeness of individual registration was 97.5 % 
(9). The register includes information about patient age, sex, diagnosis, side, surgical 
approach, type of fixation, implant design and type of hospital performing the operation 
etc. Until 1998 data on type of incision used was collected on hospital level, thereafter 
this information has been recorded on an individual basis. 
 
1.5.2.2 Reoperation  
The SHAR definition of reoperation is “any subsequent surgery in close relation to the 
already implanted prosthesis”. Every reoperation is to be reported to the register. 
Revision of a prosthesis denotes a reoperation where parts, or the entire prosthesis is 
exchanged or extracted. In the reoperation database the reason for the surgery as well as 
surgical procedure, date, new implant (if applicable) is recorded. By combining the data 
with the primary database and the data in the Swedish Death Register the “survival-
time” of the prosthesis can be calculated. To automatically evaluate the completeness 
of registration in the reoperation database is more difficult compared to the primary 
database as there are many more possible procedure codes and as the NPR is not side 
specific. The overall completeness has despite this been found to be high (76), which is 
a prerequisite to use the register as research material. That the data recorded in the 
register is correct is guaranteed as the medical records of the reoperation is sent to the 
SHAR for central register imputing.  
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1.5.2.3 PROM programme in the SHAR 
The SHAR gradually introduced pre- and postoperative Patient Reported Outcome 
Measures (PROMs) from 2002. By 2009 the PROM programme had been adopted by 
all operating units in Sweden. The response rate of the questionnaires in the PROM 
programme varies between 86 and 90 % (77). The high response rate is likely a result 
of a motivated group of patients, a short and easy questionnaire (both available as a 
paper-questionnaire and internet-based) and a well-established central and hospital 
register organization.  
 
1.5.2.3.1 Generic PROM instruments in SHAR 
The patients’ general health is estimated by the generic health instrument EQ-5D 
developed by the EuroQol group (78). It is self-administered by the patient and divided 
into two parts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. 
Swedish Hip 
Arthroplasty 
Register Annual 
Report 2012 (in 
Swedish) 
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For each of the following five dimensions the patient classifies their health into 3 levels 
of severity (1 through 3: no problems, some problems or severe problems): 
 
 Mobility,  
 Self-care, 
 Usual activities,  
 Pain / Discomfort and  
 Anxiety / Depression.  
 
A total of 243 combinations of answers are possible. The different dimensions are 
weighted separately depending on country of residence into an index (EQ-5DINDEX) 
spanning from -0,594 through 1. Answers below 0 describes a health condition worse 
than death and 1 describes full health. The instrument used in the SHAR is translated 
into Swedish, but is weighted by the British tariff (79) as no Swedish tariff has been 
developed.  
 
The preoperative EQ-5DINDEX show a bimodal distribution with a few top values. After 
THA the distribution show a trimodal distribution with a large group reporting top 
values (63).   
 
Apart from the index the instrument includes a self-reported estimation of the general 
health on a visual analogue scale (VAS), 0 (=worse possible health state) to 100 (=best 
possible health state) (EQVAS). 
 
The patient is asked to complete the EQ-5D questionnaire prior to the planned primary 
THA and again 1, 6 and 10 years after the primary THA to evaluate the perceived 
HRQoL.  
 
1.5.2.3.2 Disease specific PROM instruments in SHAR 
The preoperative questionnaire includes a VAS of pain (PainVAS) in the hip planned for 
a THA. The VAS ranges from 0 (no pain) to 100 (worst imaginable pain). The patient 
is asked to “Put a cross on the line that you think corresponds to your average pain 
perception from the hip in question during the last month”. Below the scale there are 5 
subcategories of pain: 0-20 no or slight pain, 21-40 mild pain, 41-60 moderate pain, 61-
80 severe pain and 81-100 unbearable pain. Postoperatively the patient is asked to 
report the pain from the current hip at 1, 6 and 10 years after the THA and the same 
VAS as preoperatively is used.  
 
The patient is also asked for their satisfaction with the procedure at 1, 6 and 10 years 
after the operation. Satisfaction is measured on a VAS where the patient is asked to 
“Put a cross on the line that you think corresponds to how satisfied you are with the 
result of the surgery”. The scale ranges from 0 to 100 and divided into 5 subcategories: 
0-20 very satisfied, 21-40 satisfied, 41-60 moderately satisfied, 61-80 doubtfully 
satisfied and 81-100 dissatisfied.  
 
VIKTOR LINDGREN                                                                                                                                                        13   
 
 
Compared to an ordinary VAS the scales used in the SHAR is thus adapted for two 
reasons. To be easier for an older population to understand and to be able to use both on 
a computer screen and in a pen and paper form.   
 
Both preoperatively and in the postoperative follow-ups the patients are also asked to 
report their hip function according to the Charnley functional categories developed by 
Sir John Charnley (80). Category A denotes a patient who has unilateral hip disease, 
Category B denotes a patient with bilateral hip disease and Category C denotes a 
patient with multiple joint disease or other medical condition resulting in difficulties to 
walk normally. The registered category is determined by the questions “Do you have 
any symptoms from the other hip?” and “Do you have problems walking because of 
other reasons? (E.g. pain from other joints, back pain, angina, or any other medical 
condition impairing your walking capacity)”. 
 
1.5.3 The National Patient Register  
The NPR was started in the 1960s by the Swedish National Board of Health and 
Welfare in order to collect inpatient data from the public hospitals in Sweden. It 
contains information about the care episode and is divided into 4 different categories, 
patient data (including personal registration number, sex and age), administrative data 
(date of admission and discharge, acute or elective care), geographical data (hospital 
and department), medical data (main and secondary diagnosis, cause of injury and 
procedures). The diagnosis and causes of injury are set according to the International 
Classification of Diagnosis version 10 (ICD-10) since 1997. The NPR covers all 
inpatient care provided by private and public hospitals in Sweden since 1987 and all 
outpatient care since 2001. Primary care is not included. The NPR is updated once a 
year and the quality and validity of the data has been found to be high (81).  
 
1.5.4 The Swedish Prescribed Drug Register 
The Swedish Prescribed Drug Register (SPDR) is a national health care register started 
by Swedish National Board of Health and Welfare in 1999. The objective was to 
increase patient safety. Since the July 1, 2005 the personal registration number was 
included in the register and thereafter it is possible to match the data with other health 
care and quality registries. Every dispensed outpatient prescription in Sweden is 
automatically recorded in the register and the data collected contains aside from the 
personal registration number, name of the drug, the Anatomic Therapeutic Chemical 
classification (ATC-code), size of container, dose and the date of prescription and 
expedition of the drug. It also contains the instructions from the prescriber, profession 
of the prescriber, the type of clinic and region. Both oral and intravenous drugs are 
included. The register is updated each month and each year about 100 million new 
prescriptions are included.(82)  
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2 AIMS OF THE THESIS 
The aims of this thesis were to: 
 Compare the risks of revision between the posterior and direct lateral approach 
in side position in all cemented THAs in Sweden. 
 Compare the patient reported outcome measures between the posterior and 
direct lateral approach in Sweden in THAs for osteoarthritis. 
 Determine the incidence of early and delayed deep periprosthetic joint 
infections following primary THA in Sweden. 
 Determine the completeness of the Swedish Hip Arthroplasty Register in 
recording reoperations due to infection after primary THA. 
 Explore possible risk factors to develop a deep periprosthetic joint infection 
after primary THA.  
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3 PATIENTS AND METHODS 
 
 
 
            Figure 7. Sources of data in the included studies 
 
3.1 STUDY I 
Data between 1992 and 2009 was extracted from the SHAR for the 3 most used stems 
still in use 2009; Lubinus SPII, Exeter Polished and Spectron EF Primary. In order to 
reduce a potential influence of variations of the design of the cup only combinations of 
these stems with their most frequently used cemented acetabular components were 
studied. Accordingly, the Lubinus SPII stem and FAL or Lubinus All-Poly cup 
(n=66,405), the Exeter Polished with Contemporary Hooded Duration, Exeter Duration 
or Exeter All-Poly cup (n=18,711) and Spectron EF Primary stem in combination with 
the Reflection cup (n=5,546), were included. All diagnoses, except insertion of THA 
due to tumour, were included. In the analysis, diagnoses were classified as 
osteoarthritis, fracture (including both fresh fracture and sequelae after fracture) or 
other (inflammatory arthritis, sequelae after childhood hip disease, osteonecrosis or 
other) (Table 1). Bilateral operations were included. Patients operated with any other 
incision than the posterior (12) or the direct lateral with the patient in side position (17) 
were excluded. 
More patients had been operated with the Lubinus SPII stem, than with the 2 other 
designs (Table 1). The Spectron EF Primary had been inserted through a direct lateral 
incisions in 75 % of the hips, whereas this approach only had been used in 18 % of the 
cases operated with an Exeter and 25 % of those operated with a Lubinus stem. Female 
sex was more common in the Spectron group (65 %) than in the Lubinus (60 %) and 
Exeter (60 %) groups. Osteoarthritis was slightly more common in the Exeter group (83 
%) than in the Lubinus (81 %) and Spectron group (77 %). 
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Lubinus SPII 
 
Exeter Polished 
 
Spectron EF Primary 
   66,405  18,711  5,546 
    n (%)   n (%)   n (%) 
Age (years)  <50  922 (1) <50  468 (2)   
  50-59 5,903 (9) 50-59 2,099 (11) <60 393 (7) 
  60-75 36,935 (56) 60-75 10,040 (54) 60-75 2,895 (52) 
  >75 22,645 (34) >75 6,104 (33) >75 2,258 (41) 
 Mean   71  70  73 
Sex Male  26,568 (40)  7,449 (40)  1,916 (35) 
 Female  39,837 (60)  11,262 (60)  3,630 (66) 
Side Left  30,237 (46)  8,432 (45)  2,532 (46) 
 Right  36,168 (55)  10,279 (55)  3,014 (54) 
Diagnosis Osteoarthritis  53,993 (81)  15,431 (83)  4,284 (77) 
 Fracture  8,126 (12)  1,689 (9)  857 (16) 
 Other  4,286 (7)  1,591 (8)  405 (7) 
Head  Co-Cr 58,673 (88) Metal 18,711 (100) Metal 5,546 (100) 
  Ceramics 7,732 (12)     
Cup  FAL 5,142 (8) Cont HD 3,956 (21) Reflection 5,546 (100) 
  All-Poly 61,263 (92) Duration 10,325 (55)   
    All-Poly 4,430 (24)   
Approach Direct Lateral  16,493 (25)  3,291 (18)  4,174 (75) 
 Posterior  49,912 (75)  15,420 (82)  1,372 (25) 
Order 1st hip  54,710 (82)  15,457 (83)  4,581 (83) 
 2nd hip  11,695 (18)  3,254 (17)  965 (17) 
Follow-up (years)  
mean (SD)       
 All   5.7 (3.8)  6.0 (3.7)  5.3 (2.5) 
Revision due to Dislocation  2.1 (3.0)  2.6 (3.4)  2.4 (2.3) 
 to Infection  1.8 (2.1)  2.5 (3.0)  1.6 (1.4) 
 to Loosening  7.2 (3.7)  7.0 (3.8)  5.3 (2.3) 
 
Table 1. Study demographics, variables presented in numbers (%), except for follow-up time 
presented in mean (SD). 
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3.2 STUDY II 
From the SHAR all patients operated with a THA due to osteoarthritis between 2002 
and 2010 with complete pre- and 1 year postoperative PROM data registered were 
extracted. Only patients operated by the posterior approach (12) or the direct lateral 
transgluteal approach without trochanter osteotomy on either side (17) or supine (16) 
position (called direct lateral approach) were selected. If the patient had bilateral hip 
replacements only the first hip arthroplasty was included as an earlier experience might 
affect the outcome of the 
second procedure. Patients 
operated with a resurfacing 
prosthesis were excluded 
as these patients differ 
from the general 
population in age, gender 
and physical activity and 
are mainly operated by the 
posterior approach. 
A total of 42,233 patients 
met the selection criteria 
and of these the majority 
58 % (n=24,358) were 
operated by the posterior 
approach. 4,962 patients in 
the cohort had complete 6 
year postoperative data 
registered and the majority 
67 % (n=3,310) of these 
were operated by the 
posterior approach. The 
reason for a difference in 
proportions in the 1 and 6 
year cohort is the gradual 
introduction of the PROM-
program and the fact that 
surgical approach is often 
related to the operating 
clinic. The majority of the 
patients were women (58 
%) and the proportion of reported Charnley category was similar in the two groups with 
the majority of the patients in group A and C. 
 
  
 
Figure 8. Study II Flowchart 
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3.3 STUDY III & IV 
All operations between July 1, 2005 and December 31, 2008 reported to the Swedish 
Hip Arthroplasty Register for a primary THA were included in the study (n=49,219). 
All diagnoses, bilateral arthroplasties and all types of implants regardless of the method 
of fixation were included. By using the patients’ personal registration number, the 
cohort was then matched with the Swedish Prescribed Drugs Register for all dispensed 
antibiotic prescriptions between July 1, 2005 and December 31, 2010.  
As current recommendations in Sweden for treatment of PJIs all include long term 
antibiotic treatment (83) and as uncomplicated wound infections were excluded the 
search was limited to include only the dispensed amount of antibiotics suggesting a 
continuous medication for ≥28 days (Table 15). The observation time was limited to 2 
years after the primary THA for each patient as the object of interest was early and 
delayed PJIs. The dispensed antibiotics where the instruction from the prescribing 
doctor specifically indicated treatment for other infection (e.g. urinary tract infection, 
pneumonia) than a PJI were excluded. 
1,989 patients with 2,217 THAs had been prescribed and dispensed >4 weeks of 
antibiotic treatment within the first 2 years after the primary THA. A questionnaire for 
each of the 2,217 THAs, including a list of dispensed antibiotics, was sent to a doctor at 
the primary operating unit (76 different units) to complete and return.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Study III & IV Flowchart 
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Of the 2,217 questionnaires sent out, 2,191 (99 %) were returned and all orthopedic 
clinics contributed. 4 of the patients had incorrectly been registered in the SHAR as 
primary THA when in fact they had a revision THA. These cases were excluded 
reducing the final study group to 2,187 THAs in 1,959 patients.  
 
In the questionnaire the receiving physician verified if the patient had been treated for a 
deep PJI after the primary THA. If so, supplementary information on date of diagnosis 
and how the diagnosis was set including clinic presentation, laboratory markers and 
number of positive cultures.  
 
In Study 3, the diagnosis of deep PJI was established when a patient met one or more of 
the following objective criteria (adapted from the definition established by the 
Workgroup of the Musculoskeletal Infection Society) (84): 
1. Open sinus tract to the joint. 
2. 2 or more positive perioperative cultures of the same pathogen. 
3. When the patient met 2 or more of the following criteria: 
a) Systematic infection and pus in the artificial joint 
b) C-reactive Protein (CRP) >10 or                                                  
Eurythrocyte Sedimentation Rate (ESR) >30 
c) One positive culture from joint fluid aspirate. 
 
We excluded superficial infections, PJI after revision surgery and infections prior to 
THA (most often THA after failed infected osteosynthesis). 
 
Information regarding if the patient was reoperated and in that case when and which 
kind of reoperation was to be filled in. Finally the established infecting microorganism, 
if known, was to be specified. 
 
For Study 4 the reoperation database in the SHAR were searched for all reoperations 
due to infection within 2 years after the primary THA for all 49,219 THAs, to calculate 
the completeness of the data in the SHAR. 
 
3.4 STUDY V 
The study was designed as a case control study. Cases were extracted from the previous 
infection incidence study and all patients with PJI after the primary THA from 2008 
were selected as cases. To each case four controls were selected matched by age group 
(<50, 50-59, 60-75, >75) gender and hospital type (n=776). The controls were extracted 
from the SHAR and registered with a primary THA in 2008 (n=14 010 patients) with 
preoperative complete BMI, Charnley category, patient reported EQ-5D, EQ-VAS and 
pain (n=8 687 patients). 
 
The following factors were assessed: 
Patient related factors 
Data on comorbidities were extracted partly from the SHAR-database: Hip diagnosis 
(divided into groups: osteoarthritis, inflammatory joint disease, dysplasia, 
osteonecrosis, acute cervical hip fracture, tumour (including pathological fracture), 
other fracture, sequelae after fracture or sequelae after infection), BMI (underweight 
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(<18.5), normal (18.5-24.99), overweight (25-29.99),obese ( >30)), ASA-score (85) (1-
2, 3 or 4-5), preoperative Charnley category (86) (A, B or C). Patient reported 
preoperative Pain-VAS (0-no pain; 100-worse possible pain), EQ-5D index (-0.59-1) 
and EQ VAS (0-100) (continuous variables) (78, 87). Elixhauser comorbidity score 
(88) was calculated based on the ICD-10 codes from the National Patient Register 
(NPR) including all hospital in and outpatient visits for each patient 2 years prior to the 
THA (0, ≥1). 
Surgical factors 
From the SHAR data regarding cement fixation of the prosthesis (uncemented or 
fixation with antibiotic loaded cement), surgical approach (posterior, lateral in side, 
lateral in supine position or other) and bilateral operations on the same day (yes or no) 
were extracted. 
Environmental factors  
From the previous study of PJI infection incidence the PJI incidence for 2007 
(continuous scale) as well as the volume of THAs 2007 (continuous scale) for each of 
the operating units was calculated. 
 
3.5 ETHICS 
Ethical permissions for all studies were obtained from the Regional Ethics Committee 
in Gothenburg, Sweden. For Study I and II on January 23, 2012 (ref no 1136-11) and 
for study III - V on October 11, 2010 (ref no 553-10).  
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4 STATISTICAL METHODS 
4.1 STUDY I 
Follow-up started on the day of the primary THA operation and ended on the day of 
revision, death, emigration or by December 31, 2009. Separate Cox proportional hazard 
models were used to analyse the 3 designs of implants. For each implant 3 endpoints 
were used, revision because of infection, dislocation or aseptic loosening. Adjustment 
for age, sex, diagnosis, side, design of the acetabular cup, and number of operation 
(first or second in the same patient) was done. In the groups operated with Lubinus SP 
II and Exeter stems age was divided into 4 groups (<50, 50-59, 60-75, >75 years). In 
the Spectron EF Primary group the classification was condensed into 3 groups because 
small number of cases (n<100) in the youngest group. The adjusted relative risk ratio 
(RR) of revision with 95 % confidence interval (CI) for the different surgical approach 
is presented.  To investigate the assumption of proportionality, hazard function plots 
and log-minus-log plots of all covariates were visually inspected. For each of the 
analyses there was no sign of insufficient proportionality, and log-minus-log plots ran 
parallel for all covariates.  
 
4.2 STUDY II 
All PROMs were calculated in means with standard deviation (SD) and medians with 
interquantile range (IQR). Differences in proportions were calculated by the chi2 test, 
differences in means were calculated by the 2 sample independent T-test or analysis of 
variance (ANOVA) as appropriate. Group ranks and differences in medians were 
calculated by Mann-Whitney U test. Probability values < 0.01 were considered 
significant and 99 % Confidence Intervals (CI) were chosen. Linear regression was 
used with 1 year postoperative EQ-5DINDEX and PainVAS as dependent values and 
surgical approach, age, gender, preoperative value of the index of interest, method of 
fixation (cemented, uncemented, hybrid or reverse hybrid) and preoperative Charnley 
category (A, B or C) (86) as independent values. 
 
4.3 STUDY III 
Incidence of PJI was described both as the 2-year cumulative incidence and incidence 
density rate.  Each individual primary THA was studied separately (thereby including 
patients with bilateral THA). The cumulative incidence was calculated by dividing the 
total number of identified cases within 2 years after the primary THA by the total 
number of THAs in patients still alive and unrevised (except for infection) at 2 years 
after the primary operation. The incidence density rate was described by the number of 
diagnosed infections divided by the number of THAs at risk within two periods of time, 
before 3 months and 3-24 months. Incidence density rates were expressed per 10,000 
THA-weeks, where a THA-week is a unit of follow-up equal to one THA followed for 
one week. THAs in patients that died within each time period were censored and once a 
THA was infected it was excluded for further follow-up time. Confidence intervals were 
calculated based on the binomial distribution with the Wilson score interval. Cumulative 
incidence was also calculated by each half year within the study period and trends were 
tested with the Binomial Proportion Trend test. Time to diagnosis was described as a 
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median. If the date of diagnosis was missing, the first reoperation date was chosen as 
date of diagnosis.   
 
4.4 STUDY IV 
The cumulative incidence of reoperation due to infection was calculated by dividing the 
number of reoperated THAs (in both questionnaire and SHAR reoperation data) by the 
total number of primary THAs in Sweden between July 1, 2005 and December 31, 
2008 excluding the THAs in patients that died without reoperation within 2 years after 
the primary THA (n= 47,358). Each THA was studied separately as one patient could 
have more than one THA. Each reoperated THA was only counted once even though it 
might have been reoperated several times. Completeness of reoperation registration in 
the SHAR was calculated by dividing the number of THAs that were registered with a 
reoperation due to infection registered in the SHAR with the total number THAs with a 
known reoperation due to infection based on the information from the questionnaire 
and SHAR. 
 
4.5 STUDY V 
We used generalized linear mixed model with binary outcome (infection yes or no) to 
explore the effect of patient related, surgical and environmental factors on 
postoperative PJI. Every clinic was assumed to have a different baseline infection risk 
(different intercept in the model). Both Univariate and Multivariate regression analysis 
were used to explore the Odds ratio for each variable in the model. 95 % Confidence 
Intervals were chosen and p-values <0.05 were considered significant. Missing PROM 
data for the cases (n=23) were imputed using Multivariate Imputations by Chained 
Equations.  
 
4.6 SOFTWARE 
All statistical analyses were carried out in the IBM SPSS Statistics software (versions 
19-22) for Windows. 
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5 RESULTS 
5.1 STUDY I 
Lubinus SPII 
Use of the direct lateral approach decreased the risk with 34 % of subsequent revision 
due to dislocation (RR 0.7 CI: 0.5-0.8) compared to the posterior approach. Increased 
risk was observed for males, patients with diagnosis other than osteoarthritis and use of 
the FAL cup (Table 9). Most commonly the cup was exchanged (51 %) with or without 
stem exchange (Table 10).  
 
The choice of surgical approach had no influence on revision rate due to infection. 
Male sex and patients with fracture or sequelae after fracture had an increased risk of 
revision because of infection. 
 
Hips operated through a direct lateral approach showed a slightly higher probability for 
revision due to aseptic loosening (RR 1.3 CI: 1.0-1.6). Young age and male sex also 
had a negative influence, whereas the FAL cup and the ceramics head proved to be 
associated with decreased risk to undergo revision due to loosening. Most frequently 
both components were revised (48 %) followed by a cup revision only (30 %) (Table 
10). 
 
Exeter Polished 
With the Exeter prosthesis the surgical approach did not influence the risk of revision 
for either dislocation, infection or aseptic loosening.  Male sex and other diagnoses than 
osteoarthritis had a negative effect on implant survival with regard to revision due to 
infection and dislocation (Table 11).  
 
Young age and use of the All-Poly cup were associated with increased risk of revision 
due to loosening. Most commonly the cup (59 %) or the cup and stem (32 %) were 
exchanged during revision due to loosening (Table 12). 
 
Spectron EF Primary 
Use of the direct lateral approach decreased the risk of revision due to dislocation (RR 
0.3 CI: 0.1-0.4), whereas fracture diagnosis increased this risk (Table 13). Most 
commonly the cup, with or without stem exchange, were revised when this 
complication occurred (32 of 44 cases, 73 %) 
 
The choice of approach had no influence on the risk of revision due to infection. The 
only obvious risk factor for this complication was male sex (Table 13).  
 
The direct lateral approach implied a higher risk of revision due to aseptic loosening 
(RR 1.6 CI: 1.0-2.5) as did low age (Table 13).  Most frequently the cup (49 %) or both 
components (33 %) were revised for this diagnosis (Table 14).  
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Figure 10. Cumulative survival for the Lubinus SPII prosthesis by either Posterior or Direct lateral 
approach in side position calculated by Cox Regression analysis with revision due to dislocation (top) 
and due to aseptic loosening (bottom). 
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5.2 STUDY II 
Overall, favorable statistical significant mean differences were seen postoperative in all 
aspect of the PROMs investigated. 
 
  Posterior 
mean (SD) 
Lateral 
mean (SD) 
 
Difference 
 
99 % CI 
 
p-value* 
EQ-5DINDEX   Pre-op 0.42 (0.31) 0.42 (0.31) 0 -0.01, 0.01 0.9 
 1y postop 0.79 (0.23) 0.77 (0.24) -0.03 -0.03, -0.02 <0.001 
 6y postop 0.76 (0.26) 0.73 (0.28) -0.03 -0.05, -0.01 <0.001 
EQVAS       Pre-op 54 (22) 54 (22) 0.5 -0.7, 0.2 0.023 
 1y postop 76 (20) 75 (20) -1.5 -1.0, -2.0 <0.001 
 6y postop 72 (21) 70 (22) -1.8 -3.5, -0.1 0.005 
Pain       Pre-op 62 (16) 62 (16) 0.2 -0.6, 0.2 0.278 
 1y postop 13 (17) 15 (19) 1.5 1.0, 2.0 <0.001 
 6y postop 15 (19) 17 (20) 2.3 0.8, 3.8 <0.001 
Satisfaction 1y postop 15 (19) 18 (22) 2.9 2.3, 3.4 <0.001 
 6y postop 15 (19) 19 (23) 3.2 1.5, 4.9 <0.001 
 
Table 2. Mean values for all PROMs for the posterior and direct lateral approach including differences. 
*by chi2-test 
 
EQ-5D 
The mean preoperative EQ-5DINDEX for the two groups was equal but the 1-year 
postoperatively mean EQ-5DINDEX value was significantly higher in the posterior group 
compared to the direct lateral group. This difference persisted after 6 years (Table 2). 
The preoperative impairment (i.e. reporting anything than “no problems”) was greatest 
in the Pain/Discomfort and Mobility dimensions where almost all patients (93 vs. 99 % 
respectively) indicated impairment, followed by the Usual Activities dimension. There 
was no difference in preoperative impairment between the two groups except for the 
Anxiety/Depression dimension where there was a small but significant greater 
impairment in the direct lateral group. As a consequence the greatest postoperative 
improvement was seen for both groups in the Pain/Discomfort and Mobility aspects of 
the EQ-5D instrument. These two dimensions and the Usual Activities dimension also 
showed greatest difference between the two groups where a greater proportion of the 
posterior group reported improvement at both 1 and 6 years after surgery. Both groups 
improved as much in the Self-Care or Anxiety/Depression dimensions where no 
statistical significant differences were observed. (Table 3) 
The mean preoperative EQVAS were equal in the two groups but improved to a 
significantly higher postoperative mean for the posterior group in both the 1 and 6-year 
follow-up (Table 2). 
Univariate regression analysis revealed that the posterior surgical approach increased 1-
year post-operative EQ-5DINDEX with 0.025 (99 % CI: 0.019, 0.031). This change was 
persistent even after adjusting for pre-operative EQ-5DINDEX, gender, age, Charnley 
category and method of fixation (0.027, 99 % CI: 0.021, 0.032). 
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EQ-5D dimension Pre-operative 
impairment 
1-year 
improvement 
6-year 
improvement 
Mobility     
Posterior 93 % 58 % 52 % 
Lateral 93 % 49 % 48 % 
p-value* 0.051 < 0.001 0.001 
Self-care     
Posterior 23 % 19 % 20 % 
Lateral 23 % 19 % 19 % 
p-value* 0.179 0.434 0.374 
Usual activities    
Posterior 61 % 47 % 48 % 
Lateral 61 % 45 % 44 % 
p-value* 0.190 < 0.001 0.003 
Pain/discomfort    
Posterior 99 % 66 % 65 % 
Lateral 99 % 63 % 61 % 
p-value* 0.976 < 0.001 0.006 
Anxiety/depression     
Posterior 41 % 27 % 25 % 
Lateral 43 % 27 % 27 % 
p-value* < 0.001 0.583 0.052 
 
Table 3. Differences in EQ-5D dimensions in the two groups *by chi2-test 
 
Pain 
A Box-plot reveals that the distribution of preoperative reported pain values were 
similar in the two groups. The postoperative values in the posterior group were 
however more condensed in the lower region of the scale compared to the direct lateral 
group both at 1 and 6 years. The postoperative median was lower in the posterior group 
compared with the direct lateral group at both 1 year 8(IQR:20) vs 9 (IQR:24) and 6 
years 8 (IQR:20) vs 10(IQR:30). The difference was significant (p<0.001) and ranks 
were lower for the posterior group. (Figure 11) 
 
 
 
Figure 11. Box-Plot of preoperative (left) and 1 year (middle) and 6 years (right) postoperative 
reported Pain (0-No pain, 100-Unbearable pain) for the two groups. 
 
The mean preoperative pain was severe and equal in the two groups but the posterior 
group reported less pain at one year compared to the direct lateral group. The reported 
pain slightly increased at 6 years but the difference between the two groups remained. 
The difference was significant with p<0.001 both at 1 and 6 years. (Table 2)   
The proportion of patients reporting no or light pain was larger in the posterior group 
(78 %) compared to the direct lateral group (74 %) at 1 year (p<0,001, chi2-test). This 
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proportion had decreased slightly at 6 years in both groups to 75 and 69 %, still with 
significant differences between them (p<0.001, chi2-test). 
Univariate regression analysis revealed that the posterior surgical approach decreased 
1-year post-operative PainVAS with -1.502 99 % CI: -1.956, -1.047). This change was 
persistent even after adjusting for pre-operative PainVAS, gender, age, Charnley 
category and method of fixation (-1.670, 99 %CI: -2.119, -1.220). 
 
Satisfaction 
A box-plot reveals that the satisfaction values reported by the group operated by the 
posterior approach were more condensed in the lower part of the scale and had fewer 
high values. The postoperative median was 10 for both groups at 1 and 6 years but the 
IQR was lower (24 vs 29) at 1 and 6 years as well as the ranks (p<0.001) for the 
posterior group. (Figure 12) 
 
 
 
Figure 12. Box-Plot of 1-year (left) and 6-year (right) postoperative reported Satisfaction (0- very 
satisfied, 100-dissatisfied) for the two groups. 
 
 
Patients operated through the posterior approach reported better mean satisfaction 
compared to the direct lateral approach and this difference was significant (p<0,001). 
The difference was unchanged after 6 years (p<0.001). (Table 2) 
 A larger proportion of the patients operated through the posterior approach reported 
that they were satisfied or very satisfied (90 % at 1 and 6 years) with the result of the 
surgery compared to the direct lateral (86 % at 1 year, 85 % at 6 years), a difference 
found to be statistically significant (p<0.001, chi2-test).  
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5.3 STUDY III 
443 THAs were treated for a deep PJI, representing an overall cumulative incidence of 
0.9 % (95 % CI: 0.85-1.02). When dividing the 3.5 year study period into half-years an 
increasing incidence was found (Figure 13). 91 % of the deep PJIs were re-operated 
(n=405) as part of the treatment and 90 % (n=398) were diagnosed according to the 
specified objective criteria (Table 4). 
 
Diagnosis criteria n % 
1) Open sinus tract to the prosthesis 64 14.4 
2) 2 or more positive perioperative cultivations  263 59.4 
3a) + 3b) (Systemic infection and pus in joint + elevated CRP/ESR)  23 5.2 
3a) + 3c) (Systemic infection and pus in joint + cultivation from joint aspirate ) 19 4.3 
3b) + 3c) (elevated CRP/ESR + cultivation from joint aspirate) 29 6.5 
Clinical diagnosis / information lacking in questionnaire 45 10.2 
Total 443 100 
 
Table 4. Distribution of diagnosis criteria  
(CRP=C-reactive Protein, ESR=erythrocyte sedimentation rate) 
 
 
Figure 13. The cumulative incidence (with 95 % Confidence Interval) of deep periprothetic joint 
infection after total hip replacement specified for each half-year of the study period. 
 
425 patients had a specified date of diagnosis or reoperation date and the median time 
to diagnosis was 24 days (Figure 14). The incidence density rate within the first three 
postoperative months was 5 cases per 10,000 THA-weeks (95 % CI: 4.70-5.83) and for 
the remaining 3-24 months it decreased to 0.3 cases per 10,000 THA-weeks (95 % CI: 
0.21-0.31).  
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Figure 14. Histogram illustrating time from primary total hip replacement to diagnosis of deep 
periprosthetic infection, each bar representing one week. 
 
The cumulative incidence of the individual clinics ranged from 0 to 4.2 % (median 0.8 
%).  
 
In 393 of the 443 deep PJIs a known pathogen was specified. Coagulase Negative 
Staphylococci (CNS) and Staphylococcus Aureus (SA) were alone or in combination 
with other microorganisms responsible in 70 % of the cases (Table 5). 
 
 
Microorganism  n  % 
Polymicrobial* 109 24.6 
CNS 109 24.6 
SA 89 20.1 
Streptococci 32 7.2 
Enterococcus feacalis 16 3.6 
Miscellaneous 38 8.6 
Unknown 50 11.3 
 Total 443 100 
* all including either SA and/or CNS  
CNS = Coagulase Negative Staphylococcus 
SA = Staphylococcus Aureus  
 
Table 5. Distribution of infecting microorganism 
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5.4 STUDY IV 
A total of 599 primary THAs were reoperated due to infection within 2 years after the 
primary operation making the cumulative incidence 1.3 %. Of these, 400 THAs were 
registered for a reoperation due to infection in the SHAR, resulting in an overall 
completeness of 67 %. The THAs with missing reoperation in the SHAR included all 
types of reoperations (Table 6). 
 
 
Type of reoperation total  
Non-registered in 
SHAR 
  n %  n % 
Reoperation without revision of prosthesis      
Wound revision 103 17.2  58 29.1 
Irrigation of prosthesis 212 35.4  79 39.7 
Total 315 52.6  137 68.8 
Revision of prosthesis      
Exchange of parts or entire prosthesis 173 28.9  45 22.6 
Extraction (with or without spacer) 111 18.5  17 8.5 
Total  284 47.4  62 31.2 
Total  599 100  199 100 
 
Table 6. Type of reoperation due to infection within 2 years after primary THA, total numbers and 
non-registered cases in the Swedish Hip Arthroplasty Register (SHAR) 
 
 
The number of non-registered reoperations for the individual primary operating units 
ranged between 0 to 100 % and was not associated to the total number of reoperated 
infections by each unit (Figure 15). 
 
 
 
Figure 15. The number of registered and non-registered reoperated primary THAs, within 2 years after index 
operation due to infection in the Swedish Hip Arthroplasty Register (SHAR), for each primary operating unit. 
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5.5 STUDY V 
Cases vs Controls 
Compared to the controls the cases were less often of normal weight, were more often 
of ASA-score 3, had more often Elixhauser ≥1 and had less often osteoarthritis (all 
p<0.001). They were more often operated by the direct lateral approach in side position 
and were more often operated by a unit with greater PJI incidence (p=0,031 and 0,041) 
(Table 7). 
 
Patient related factors. 
Both comorbidity measures (ASA- and Elixhauser score) had significant influence on 
the risk of PJI both in the uni- and multivariate analysis with increasing comorbidity 
(both p=0.01). Fracture diagnoses had increased odds for infection in the univariate but 
not in the multivariate analysis. Charnley category did not affect the risk of PJI and the 
preoperative PROMs had only limited effect on the univariate and multivariate analysis 
(Table 8).  
Regarding BMI, both underweight and obesity had significant increased odds for PJI 
both in the uni- and multivariate analysis (p=0.006 and p<0.0001). 
 
Surgical related factors. 
The direct lateral surgical approach in side position showed increased risk of infection 
in the univariate analysis but none of the selected surgical related factors showed any 
increased risk of PJI in the multivariate analysis (Table 8).  
 
Environmental related factors 
The previous year infection incidence contributed to increased risk of PJI in the 
univariate model but none of the investigated environmental related factors showed 
increased risk of PJI in the multivariate analysis (Table 8). 
  
VIKTOR LINDGREN                                                                                                                                                        33   
 
 
Variable   Cases Controls P-value 
Sample size  194 776  
Female gender (%)  95 (49.0) 380 (49.0) 1.000 
Age group (%)    1.000 
   <50  5 ( 2.6) 20 ( 2.6)  
   50-59  27 (13.9) 108 (13.9)  
   60-75  97 (50.0) 388 (50.0)  
   >75  65 (33.5) 260 (33.5)  
Hospital type (%)    1.000 
   University/Regional  31 (16.0) 124 (16.0)  
   Central  84 (43.3) 336 (43.3)  
   Rural  65 (33.5) 260 (33.5)  
   Private  14 ( 7.2) 56 ( 7.2)  
BMI (%)    <0.001 
   Underweight  9 ( 4.6) 6 ( 0.8)  
   Normal  43 (22.2) 260 (33.5)  
   Overweight  74 (38.1) 344 (44.3)  
   Obese  68 (35.1) 166 (21.4)  
Elixhauser ≥1  (%)  43 (22.2) 74 (9.5) <0.001 
ASA classification (%)    <0.001 
   1-2  128 (67.4) 640 (82.5)  
   3  56 (29.5) 128 (16.5)  
   4-5  6 ( 3.2) 8 ( 1.0)  
Charnley classification (%)    0.140 
   A    74 (39.8) 361 (46.5)  
   B    16 ( 8.6) 77 ( 9.9)  
   C    96 (51.6) 338 (43.6)  
Hip diagnosis (%)    <0.001 
  Osteoarthritis  139 (71.6) 708 (91.2)  
  Other  2 ( 1.0) 1 ( 0.1)  
  Acute cervical neck fracture  12 ( 6.2) 4 ( 0.5)  
  Dysplasia  10 ( 5.2) 31 ( 4.0)  
  Sequele after fracture  16 ( 8.2) 19 ( 2.4)  
  Other fracture  3 ( 1.5) 0 ( 0.0)  
  Inflammatory joint disease  3 ( 1.5) 9 ( 1.2)  
  Osteonecrosis  5 ( 2.6) 4 ( 0.5)  
  Post infection  1 ( 0.5) 0 ( 0.0)  
  Tumour (incl path fracture)  3 ( 1.5) 0 ( 0.0)  
Preop Pain VAS (mean (SD))  64.15 (15.84) 61.27 (16.65) 0.067 
Preop EQ-5D index (mean (SD))  0.35 (0.33) 0.41 (0.31) 0.062 
Preop EQ VAS (mean (SD))  51.09 (20.46) 53.24 (21.35) 0.287 
Surgical approach (%)    0.031 
   Posterior  76 (39.2) 390 (50.3)  
   Lateral Side Position  108 (55.7) 351 (45.2)  
   Lateral Supine Position  9 ( 4.6) 26 ( 3.4)  
   Others  1 ( 0.5) 9 ( 1.2)  
Cemented fixation (%)  164 (85.9) 668 (86.1) 1.000 
Bilateral THRs (%)  2 (2.0) 3 (0.4)  
Infection rate 2007 (mean (SD))  1.58 (1.17) 1.40 (1.09) 0.041 
No of THRs 2007 (mean (SD))  270.89 (194.62) 275.82 (184.26) 0.742 
 
Table 7. Demographics of cases and controls. Categorical variables presented in numbers and percentages 
and continuous variables presented in means with standard deviation (SD). P-values calculated by t-test or 
Chi2- test as appropriate. 
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 Univariate  Multivariate 
Variable OR 95  % CI P-value OR 95  % CI P-value 
Patient related factors       
BMI Underweight 8.53 2.83;  25.68 <0.0001 5.39 1.63; 17.83 0.006 
 Normal ref   ref   
 Overweight 1.42 0.92; 2.17 0.106 1.36 0.88; 2.11 0.158 
 Obese 3.14 1.98; 4.96 <0.0001 2.75 1.72; 4.39 <0.0001 
Elixhauser score  0 ref   ref   
 ≥1 2.13 1.4: 3.25 <0.0001 1.76 1.12; 2.52 0.01 
ASA score  1-2 ref   ref   
 3 2.28 1.56; 3.32 <0.0001 1.68 1.12; 2.52 0.01 
 4-5 - - -    
Charnley category A ref      
 B 0.99 0.53; 1.84 0.610    
 C 1.32 0.93; 1.88 0.634    
Hip Diagnosis  Osteoarthritis ref      
 Infl. joint disease 0.91 0.25  3.23  0.880    
 Dysplasia 1.51 0.69; 3.30  0.296    
  Osteonecrosis 1.49 0.52; 4.25 0.455    
  Acute Cervical fracture 15.7 4.82; 51.29 <0.0001    
 Other fracture - - -    
 Tumor (incl. path fx) - - -    
 Sequelae after fracture 2.83 1.47; 5.47 0.002    
 Post infection - - -    
  Other - - -    
Pain VAS  1.01 1.002; 1.02 0.02 1.01 1.003; 1.025 0.014 
EQ5D index  0.47 0.26; 0.87 0.014    
EQ VAS  0.99 0.98; 1.001 0.101    
Surgical related factors       
Surgical approach Posterior ref      
 Lateral in Side 1.82 1.24; 2.68  0.002    
 Lateral Supine 1.96 0.79; 4.84  0.142    
 Others 0.54 0.065; 4.48 0.569    
Prosthesis fixation Uncemented ref      
 Cemented 0.838 0.52; 1.35 0.47    
Bilateral surgery No ref      
 Yes 2.78 0.41; 19.09 0.29    
Environmental related factors       
Infection rate 2007  1.19 0.99;1.43 0.05    
No of THAs 2007  0.99 9.98; 1.01 0.25    
 
Table 8. Uni- and multivariate analysis with Odds Ratio (OR) of risk factors including 95 % Confidence Intervals (CI) and 
p-values, non-significant values excluded in the multivariate analysis. 
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6 DISCUSSION 
6.1 SURGICAL APPROACH  
The role of surgical approach in THA is an often debated issue and is not ended by this 
thesis. The change in distribution of surgical approaches in the SHAR over the years is 
probably a result of an attempt of orthopedic surgeons to improve the outcome of 
THAs. The most common early prosthesis related complication that has a relatively 
strong correlation to surgical approach is dislocation. This correlation seems even 
stronger considering that cervical femur fracture is an increasing indication for THA 
and in this group the surgical approach has great impact on dislocation risk (10). It can 
therefore be assumed that the increase in direct lateral approach seen in recent years is 
to reduce the risk of dislocation especially for training specialists finding their preferred 
approach. However, separation of reason for revision is important as the type of 
incision may reduce the risk of one complication but on the same time increase the risk 
of another complication. If these outcomes are compiled the overall risk may become 
neutralized and also more dependent on time to follow up since revisions due to 
loosening tend occur much later than those performed due to dislocation. 
 
The findings in this study support the previous studies that the direct lateral approach 
decrease the risk of dislocation in THA (14, 15). An unexpected finding was that the 
Exeter prosthesis did not have a higher revision rate due to dislocation when inserted 
through a posterior approach. The reason for this is difficult to explain. It is possibly an 
effect of its head and neck design and/or the design of the cup rather than its straight 
tapered collarless stem. Stem revision after recurrent dislocation was more common for 
the Exeter prosthesis compared to Lubinus and Spectron, suggesting that correct stem 
placement is more difficult or perhaps that the Exeter stem is easier to revise. 
 
Aseptic loosening of the implant is the most common reason for revision of a THA. 
There is only one previous study addressing the question of the impact of surgical 
approach on prosthetic loosening; Arthursson et al (2007) found that the Charnley 
prosthesis inserted through a direct lateral approach including trochanteric osteotomy 
was associated with lower revision rates both due to dislocation and aseptic loosening 
compared to those implanted using either a posterior or direct lateral approach without 
trochanteric osteotomy (89). They also found that use of the posterior or direct lateral 
approach without trochanteric osteotomy had no influence on the risk of revision of 
Exeter prosthesis.  
 
Both approaches have their advantages and shortcomings of in terms of exposure and it 
is possible that the reason for the higher revision rate for the Lubinus and Spectron 
groups might have to do with malpositioning of the components. In both clinical and 
experimental studies inclination angle of the acetabular cup greater than 50 degrees 
have been found to correlate with increased acetabular wear (26, 90) which is often 
associated with loosening of the implant. Callanan et al (2011) found that the direct 
lateral approach lead to an increasing rate of malpostioned cups defined as an 
inclination angle lower than 30 degrees or greater than 45 degrees or anteversion lower 
than 5 degrees or greater than 25 degrees (91). If the direct lateral approach lead to a 
greater risk of malpositioning of the cup this could explain the increased risk of 
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revision due to loosening after this approach. The reason why only 2 of the stems had 
inferior results with the direct lateral approach is however more difficult to explain. 
Perhaps the cups used with the Lubinus and Spectron designs are more prone to be 
malpositioned than the cup used with the Exeter at least when inserted by the direct 
lateral approach. 
 
Regarding the found differences for stems, it might be that the 2 non-polished stems are 
more sensitive to malpositioning. This can occur if the femoral canal is entered too 
anteriorly, which may be more frequent with use of a direct lateral approach. A direct 
lateral approach with a straight stem design often result in a thin cement mantle, or 
even stem-cortex contact, in the proximal anterior and distal posterior part of femur 
(92), but this might not result in an osteolysis with loosening of the polished straight 
stem (93, 94). The 2 non-polished stems are probably more sensitive to debonding and 
defects in the cement mantle resulting in higher production of cement and metallic 
debris (13). The relative distribution between cup and stem revisions with higher 
frequency of the latter procedure with the non-polished designs could support this 
theory. Poor access to the femoral canal can also lead to the use of a smaller stem size 
than appropriate. The smallest stem size of the Spectron and Lubinus design are 
associated with greater risk of loosening which also can contribute to the inferior result 
(95). The study confirmed the influence of young age and male sex as a risk factor for 
revision due to aseptic loosening. 
 
The choice of incision is related to the surgeon’s preference and experience, a factor 
that may render the interpretation of a clinical trial difficult.  Further, large numbers are 
needed to gain statistical power and especially to study burden of infection, dislocation 
and aseptic loosening (11). When addressing these types of rare events large 
prospective observational studies are preferable especially when the time period 
between intervention and outcome (such as aseptic loosening) is long (23) and are 
proven useful even in orthopaedic surgery (96). The strength of this study is thus its 
large size, long observational time and external validity due to the nationwide study 
population and that both surgical approaches as well as the implants are still in use. 
 
Neither Study 1 nor Study 5 show a correlation between surgical approach and risk of 
PJI or revision due to infection in the multivariate analysis.  
 
The primary indication for THA is to relieve pain, restore hip function and increase 
quality of life although there is great variation in the assessment of indications (97). 
Patient reported outcome in THA has known problems with ceiling effects in the 
postoperative evaluation which is due to the often excellent outcome of the intervention 
for a patient with OA (98, 99).  It is however well known that some patients respond 
poorly to the procedure and the reason for this is probably multifactorial (100, 101). 
Some patients might not be relieved of pain or suffer from a complication while others 
have other (perhaps unrealistic) expectations that are not met by the procedure. 
Although most patients have a great improvement on pain, HRQoL and hip function 
after a THA regardless of surgical approach, Study 2 indicate that the surgical approach 
does have an influence. It confirms the findings of superior PROMs after the posterior 
VIKTOR LINDGREN                                                                                                                                                        37   
 
 
approach in previous studies (68, 69), but contradicts the study that argue that the 
influence is transient (72). 
 
The results do not mean that all patients are better off if operated by the posterior 
approach. The differences of the mean values for the investigated PROMs are small, 
but could still be clinically relevant. The less favorable means for the direct lateral 
group indicate that more patients report inferior values than in the posterior groups. 
This difference could reflect a general deterioration, where most patients report minor 
inferior values with variable clinical relevance or that a smaller subset of patients in the 
direct lateral group has more pronounced problems. The latter alternative seems more 
reasonable when considering the EQ-5DINDEX. The difference in mean EQ-5DINDEX is a 
result of the difference in postoperative improvement in the different dimensions of 
EQ-5D. As the steps between the different answering options (such as no pain vs some 
or a lot of pain) are reasonably large, it is likely that this reflects a clinically relevant 
difference for some patients. The same goes for the postoperative VAS of pain and 
satisfaction shown by the box-plots diagrams and the statistically significant differences 
in percentiles (Figure 11 and 12).  
 
The strength of this study is its prospective collection of data, the nationwide design 
and a large study group making the results statistically robust and highly generalizable 
to patients undergoing THA due to OA. It is also reasonable to believe that the 
outcomes are relevant in evaluating the effect of THA. For a large number of patients 
long-term data are evaluated and the differences between the two groups persist, 
indicating a permanent state.  
 
A possible explanatory model for the difference in PROMs between the two groups 
could be the known complication of abductor weakness and Trendelenburg gait 
secondary to damage to the superior gluteal nerve or rupture/non-healing of the gluteus 
medius tendon. This condition is considered more common after insertion of a THA by 
the direct lateral approach compared to the posterior approach (15, 18, 69). This might 
be the reason why the largest difference between the two groups were detected in the 
mobility dimension of the EQ-5D instrument despite the lack of a specific information 
regarding postoperative limb. In some patients the damage to the superior gluteal nerve 
improves with time but several patients still suffer from Trendelenburg gait 1 year after 
THA (102, 103). The difference in mobility also decreases with time (1-year compared 
to 6-years postoperatively) but is still present 6 years after THA indicating a chronic 
impairment. A few patients in the direct lateral group also report less satisfaction and 
more hip related pain compared to the posterior group which could be a consequence of 
greater trochanteric pain, which might be another presentation of the same condition as 
abductor weakness. 
 
There are many ways of determining the success or failure of a THA. These large 
prospective observational cohort studies indicate that the surgical approach has an 
impact on the outcome and that this should be taken into account when planning a 
THA. Even though the direct lateral approach decrease the risk of dislocation it may 
increase the risk of aseptic loosening and result in inferior patient reported outcome in 
the unrevised patients on a population level. Despite the seemingly small differences 
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between the groups, this observation has probably clinical relevance and especially 
against the background of the permanent nature of the differences observed and the 
large number of cases operated with these approaches. Prospective and randomized 
studies in this field would be of value to obtain more information about differences in 
clinical performance and PROs after use of these two approaches and to evaluate if 
these results can be generalized to other cemented implants and implants used with 
uncemented fixation especially regarding aseptic loosening. 
 
  
6.2 PERIPROSTETHIC INFECTIONS  
The most feared complication after THA is the deep periprosthetic joint infection. The 
problem with postoperative infections is likely to increase in the future as the number 
of performed THAs are estimated to increase as the indication for THA is expanding 
including both older and more fragile patients and younger patients with high demands 
of physical activity. There is also an increasing problem of antibiotic resistant bacteria 
leading to more difficult postoperative infections. 
 
Study 3 presents a unique model to establish an incidence of deep PJI following 
primary THA by combining health registries with a medical records review. This is the 
first national incidence study by this method. As previously mentioned international 
studies have determined the PJI incidence after primary THA to between 0.2 and 1.6 % 
(42, 43). The different results in these studies suggests that the diagnosis criteria, the 
study population, and perhaps most importantly the length of follow-up have significant 
influence on the results.  
 
The incidence of PJI is not always easy to determine in clinical practice since the 
predictive power of a single test is low. Many observations taken together such as 
clinical presentation, laboratory findings in blood and in joint aspiration, radiographic 
findings, histology and most importantly cultures are often used and needed to establish 
a diagnosis of PJI (104, 105). Cultures indisputably have a central role in the diagnosis 
but have considerable risks of being both false positive (contamination) and false 
negative due to preoperative antibiotic treatment, biofilm formation, poor managed 
samples and a lacking standard for cultivation (84, 106). Most studies have their own 
definition of a PJI and the historical absence of a standard makes comparisons difficult 
(107). The American Musculoskeletal Infection Society introduced a new standard in 
2011 (84) , which practical usefulness has been subject to debate (108). The new 
standards accept the fact that a PJI can be present even though the criteria of diagnosis 
have not been fulfilled. Therefore all patients where the doctor reported a deep PJI even 
though the criteria were not fulfilled were included, as the opposite would definitely 
lead to an underreporting of PJI incidence. From a patient point of view it might not 
always be of importance how the diagnosis has been set but rather the clinical 
consequences of an infection and its treatment. Although 81 different doctors reviewed 
the medical records retrospectively, introducing a variability of data quality, most of the 
deep PJI cases included enough information in the questionnaire to establish the 
diagnosis consistent with the specified criteria adapted from the Workgroup of the 
Musculoskeletal Infection Society.  
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 The incidence of infections increased during the period of observation, which has been 
suspected by an earlier study (45). Whether this is a result of deterioration of hygiene 
and prophylactic standards, increasing patient comorbidity or perhaps an increasing 
resistance and virulence of the microorganisms is however not answered by this study. 
Nevertheless it emphasizes the need for actions like the Swedish PRISS-initiative to 
reduce postoperative infection rates by improving all aspects of the pre-, per and 
postoperative care. Future studies are planned to determine the effect of this initiative in 
reducing the national infection burden. 
 
The advantage of this study is both the nationwide coverage of all THA performing 
clinics, the large study population, the long follow-up and the possibility of an objective 
assessment of the clinical course after the surgical and medical treatment. The number 
of assessed medical records and returned questionnaires by the operating units is also a 
strength of the study. Study of medical records is also likely to give a more reliable 
validation compared to other methods such as questionnaires filled in by patients or 
procedure codes in administrative databases. 
 
Compared to previous studies of national PJI incidence which are based solely on 
administrative data based on payment system (Medicare) (20, 43) the study identified 
infected patients by their treatment and not by coding of a diagnosis, a procedure which 
is probably more susceptible to different types of errors. Data based on International 
Classification of Diseases codes (ICD-codes) are easy to access and study but are 
imprecise in following specific PJIs as the codes indicating infection lack accuracy and 
are not side or joint specific. They can therefore result in an overestimation of 
infections or an underestimation depending on coding routines (20). Hopefully the 
method used in this study therefore result in a more specific and accurate estimation of 
the national incidence of deep PJIs in Sweden. 
  
Many countries have introduced mandatory surgical site infection surveillance systems 
to monitor postoperative infections after specific surgical procedures, often including 
hip replacement surgery. Sweden lack such a register but instead have a possibility to 
combine and match information in different health-care and quality registers by the 
patient’s personal registration number to find information that indicate a specific 
disease, for example infections. Therefore instead of inventing new registries a model 
for automated matching of registries in order to find possible postoperative infections is 
an attractive alternative (109). The SPDR introduces a possibility of an unbiased report 
of infection incidence as every dispensed prescription is recorded automatically. The 
SPDR seem to be sensitive in identifying patients with a possible postoperative 
infection but is not sufficient to monitor postoperative infections alone as the 
population observed have a risk of many other medical conditions requiring antibiotic 
treatment. Future studies are planned to investigate how to automatically combine 
register data in order to increase specificity and maintaining a high sensitivity without 
the need for review of medical records.   
 
The microbial spectra with a majority of CNS- and SA-caused infections are consistent 
with previous studies (47, 52). The problem with increasing incidence of Methicillin-
Resistant-Staphylococcus Aureus (MRSA) infections reported internationally does not 
40                                                                                             COMPLICATIONS AFTER TOTAL HIP ARTHROPLASTY 
 
 
seem to have been a clinical problem in Sweden 2005-2008 as no MRSA infections 
were reported (110).  
 
Study 4 presents an external validation of the SHAR reoperation database in terms of 
reoperation due to infection and shows that 67 % of the reoperated infections are 
reported to the register. The low completeness of registered reoperations due to 
infection in the SHAR varied greatly between the operating units, but seems to be a 
general problem of the Swedish orthopaedic community. The reason for the low 
completeness is probably multifactorial but one important reason might be that 
reoperations due to infection with no or minor implant exchange are performed in an 
acute setting and could therefore deviate from the standard routine reporting. Another 
reason might be that other orthopaedic quality registries (e.g. the Swedish Knee 
Arthroplasty Register) only record revisions (implant exchange or extraction) and not 
all reoperations introducing an uncertainty in the reporting routines to the SHAR. That 
68.8 % of the reoperations not reported to the register were reoperations without 
implant exchange or extraction supports this (Table 6). There is also a possibility that 
units taking care of their own complications deliberately fail to report reoperations to 
the SHAR in order to improve their results in the SHAR annual report.  However, the 
high compliance to the questionnaire, where all operating units participated speaks 
against this presumption. 
 
The validity of a total joint replacement register is dependent on the coverage and 
completeness of the register. The coverage (i.e. the number of operating units that 
report to a register) is important, but the figures can be misleading if the completeness 
(i.e. the number of correct registrations on an individual level) is low at some or all 
operating units. This can lead to both an underestimation of the true total incidence of 
reoperations and to an incorrect relative incidence between the reporting units. It is 
therefore important to evaluate both coverage and completeness so that the results can 
be interpreted with justice.    
 
Arthroplasty register data has been used to study the change of infection rates after total 
hip arthroplasty (44). An arthroplasty register only capture infections that are 
reoperated (and in some registries only the revised ones) and not the infections treated 
by antibiotics only (111). In Study 3 10 % of the deep infections during the study 
period were treated without surgical intervention. The change in infection rates can 
therefore reflect a change in reoperation policy or the change in arthroplasty modularity 
making it easier to revise the prosthesis by exchange of head or acetabular liner. The 
low completeness found in this study also imply that change in reporting routines could 
have a large impact on the change in infection rates in register data. That only 47.4 % 
of the reoperations due to infection in this study were revisions, implies that especially 
those arthroplasty registers that only record revisions seem less reliable when studying 
infection rates as revisions are dependent on the modularity of the prosthesis. In 
contrast to previous arthroplasty validation studies that have found extraction of 
prosthesis (i.e. Girdlestone procedure) due to infection to be the most common error in 
registration, this procedure was found to be the most reliable of the four categories in 
this study (112, 113). The conclusion is that national arthroplasty register data cannot 
with certainty be used as an estimation of the total infection burden after THA. 
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Study 5 confirmed the findings in previous studies that increasing ASA-score and 
obesity is associated with increased risk of PJI. It also found that underweight is a risk 
factor. The findings in the multivariate analysis suggest that the difference in incidence 
of PJIs observed in the different operating units substantially can be explained by the 
case-mix between clinics. The study indicate that further decreasing the incidence of 
PJIs after primary THA will be difficult.  
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7 LIMITATIONS 
 
7.1 GENERAL CONSIDERATIONS ON STUDIES OF ARTHROPLASTY 
REGISTER DATA. 
When studying complications there is always a risk of underestimation as 100 % 
follow-up is difficult to achieve especially if they occur long time after the intervention. 
Even in studies with data from national arthroplasty registers there is always a risk of 
underestimating the complication of interest as only re-operated or revised implants are 
recorded. Skewness in groups on e.g. age can lead to an under-representation of the 
number of patients in one group because of non-operative treatment due to old age or 
medical co-morbidity. The presence of the complication you are interested in can thus 
be influenced by the method of its treatment. 
 
The validity of a register is above all dependent on the coverage and completeness of 
the register. The coverage of the SHAR is 100 % and the completeness of primary 
procedures are 97.5 % when compared with the NPR (9). In a study of the SHAR, 
Söderman et al have concluded that the completeness of the data was high although it 
differed depending on which parameter was measured (76). The results in study 4 
highlight the problem with completeness of data. 
 
Register data can be used to see correlations between exposure and outcome but does 
not allow the possibility to make causal connections. There are many possible 
confounders that might influence both the exposure and the outcome which are difficult 
to take into account. Therefore in general the results are often used in order to create 
hypotheses later proved by clinical trials that, in theory, would distribute these factors 
equally. Practically they are however often used to complement research where clinical 
trials are not conducted due to high costs, large number of patients and long 
observation time needed. In orthopaedic surgery such confounding factors might be 
surgical skills influencing for example bleeding, implant positioning, soft tissue 
management, and operating time that can influence the outcome both in terms of 
complications and PROs. Other factors that could influence the outcome but are 
difficult to include are smoking, daily activity, education and medical or psychiatric co-
morbidity. 
 
7.2 SPECIFIC CONSIDERATIONS REGARDING STUDY I 
One concern with the study could be the skew distribution in the 3 implant groups 
between the 2 types of approaches studied. Nonetheless, the smallest group included 
more than 1 300 operations which should be sufficient for a reliable analysis. Another 
source of error could be that some cases classified as aseptic loosening were low grade 
infections. However, this would probably affect the different implant designs and 
surgical approaches evenly, especially when the study indicate that the revisions due to 
postoperative infection are equally dispersed among the different implants and surgical 
approaches. 
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From 1999 the SHAR has registered all information on an individual basis which is a 
guarantee for a reliable database. However, before this year some information was 
collected on a hospital basis meaning that variation in some variables in the same 
hospital not was considered. Instead the most commonly used variable was reported for 
all operations. Head size and surgical approach are examples of this kind of 
information. In Sweden each hospital had at that time a rather consistent use of a 
specific surgical approach and variations in head size of the prosthesis was rare. 
Nonetheless, this way of reporting means an increased risk of incorrect data collection 
during the early period of the study. This period was included to increase the 
observation time, which is of interest to obtain a better coverage of revisions due to 
loosening. Analysis of this problem based on the surgical approaches used and reported 
for individual operations performed during the year 2000 revealed that more than one 
type of approach was used on a regular basis in 12 of 55 departments, performing at 
least one of the implants in the study.  If this finding is applicable to the period 1992-
1998 this means that the relative share of misclassified cases would constitute 8.7 % of 
cases operated 1992-1998 and 2.2 % of the cases operated during the entire period of 
observation 
 
7.3 SPECIFIC CONSIDERATIONS REGARDING STUDY II 
Apart from the general considerations regarding register data studies the main 
limitation of studies on PROMs in THA is that the differences in PROMs between the 
two approaches are small although they are statistically significant. Are the differences 
truly clinically relevant? Small differences in mean values can derive from either small 
differences in many patients or large differences in a few patients or a mix of both. A 
small mean difference can however not automatically be dismissed as clinically 
irrelevant just because it is below a Minimally Clinically Important Difference (MCID) 
for an individual value. In this study the distribution in the box-plots and the cut-off 
values imply that the small and statistically significant mean difference derives from a 
large difference for a smaller group of patients. There is also risk of selection bias as 
only the patients that had completed and returned the pre- and postoperative PROM 
questionnaire were assessed.   
 
7.4 SPECIFIC LIMITATIONS REGARDING STUDY III-V 
As only outpatient antibiotic treatment is recorded in the SPDR the patients who died 
before discharge or those not receiving or complying with the antibiotic treatment 
would not be included in the questionnaire group. Also, patients never returning to the 
primary operating unit would not be recorded as a PJI or have had a reoperation even 
though they might have consumed large doses of antibiotics. This group of patients is 
not expected to be large as only long term antibiotic treatment was included and 
superficial infections were excluded in Study 3. Although the register data is collected 
prospectively, the diagnosis of PJI was set retrospectively which also is a possible 
weakness in this study. However the question if a patient had been reoperated due to 
infection is probably not affected by the retrospective analysis. With these concerns in 
mind it can be concluded that the incidence found in this study is probably a slight 
underestimation of the true incidence of PJIs and reoperations.  
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In Study 5, the nature of the data put extra strains on the statistical analyses. The 
patients were divided between 76 different clinics and the incidence rate of infections 
was generally low. As most potential predictors were categorical, some might contain 
very few observations. The direction and magnitude of the estimate odds are right, but 
due to the low incidence of the outcome their exact size might fluctuate by the addition 
or removal of a few patients in the model. 
 
The NPR (used for comorbidity assessment in study 5) has proven to have high validity 
for a registered diagnosis but the absence of a diagnosis does not mean that it does not 
exist, i.e. the sensitivity of the register is likely low as a patient need hospital in- or 
outpatient care to be associated with a diagnosis. The calculated Elixhauser 
comorbidity score is probably lower than the true score, but likely so for both cases and 
controls. Factors that have been found influential in earlier studies were included in the 
multivariate analysis but it is possible that other factors that could have an impact were 
not included. 
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8 GENERAL CONCLUSIONS 
Based on the findings in the studies of this thesis the following conclusions can be 
made: 
1. The surgical approach is a factor worth taking into account when estimating the 
risk of revision in THA as it might influence the outcome differently depending 
on the implant at hand and the cause of revision. 
2. The direct lateral approach is associated with inferior generic and hip specific 
PROMs compared to the posterior approach in THA due to osteoarthritis. 
3. The national incidence of early and delayed deep PJIs after primary THA in 
Sweden 2005-2008 was 0.9 %. 
4. The completeness of registered reoperations due to infection was 67 % in the 
Swedish Hip Arthroplasty Register during 2005-2008. 
5. In Sweden, patient related factors seem to be more influential compared to 
environmental and surgical related factors on the risk of developing a PJI within 
the first two postoperative years following primary THA. 
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9 FUTURE PERSPECTIVES 
9.1 IMPROVING THE RESULTS OF THA 
To further improve the already very good results of THAs on a population basis some 
conclusions can be made from the presented studies. They highlight the importance of 
an individualized operation related to the various facts present in each case. Many 
doctors and clinics use only one surgical approach for all patients and diagnoses. The 
results of the presented studies however indicate that not only implant choice is an 
important factor for postoperative success but also the surgical approach.  
Patients with increased risk of dislocation (such as patients with cervical hip fracture) 
motivate a THA through the direct lateral approach as this approach is in less extent 
associated with dislocation. The posterior approach should be advocated to allow for a 
greater chance of good PROMs and to decrease the future risk of aseptic loosening in 
patients with OA, especially those of young age.  
 
Regarding the risk of early and delayed postoperative infections the findings indicate 
that patient comorbidity is the most important factor on a population base. Preoperative 
optimization of the patient is therefore of great importance although some of the risk 
factors are not possible to affect. Consequently a more active postoperative regimen 
(sterile wound dressings, early follow-up with wound control etc.) should be organized 
to minimize wound healing complications and if they occur to detect these as early as 
possible especially for patients with increased risk of infections.  
 
9.2 FUTURE STUDIES 
Monitoring systems are important when trying to minimize complications. Such 
systems need to be reliable with great sensitivity as well as specificity. Preferably they 
should not be expensive to allow for frequent evaluations. Surgical site infection 
surveillance systems have not been implemented in Sweden. This is perhaps because 
they are associated with high costs. Compared to other countries Sweden has the 
advantage of the many health care and quality registers that can be linked on a patient 
level via the personal identification number, enabling a possibility to follow specific 
complications. Instead of inventing new registries, automated cross-matching between 
existing registries together with an algorithm (defining for example infections) are 
possible methods for a continuous surveillance system that is likely very cost effective. 
Before implementing such a surveillance system it needs to be validated to ensure their 
sensitivity and specificity to be used for improvement work.  
 
As the PRISS’ pre-, per- and postoperative recommendations since 2013 are fully 
adopted by all clinics in Sweden performing THAs it is possible to evaluate the effect 
of this project on the nationwide incidence of PJIs. Hopefully the initiative has been 
effective. It is however possible that the initiative has led to an increasing interest of 
PJIs among doctors leading to better diagnostics and/or prolonged treatment of PJIs 
resulting in an increasing annual incidence.   
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The economic effect of PJIs and its burden on the healthcare system has been studied 
but the effect of a PJI on PROMs have not been fully investigated. This is probably 
dependent on the microbiology and number and type of surgical interventions 
performed on each individual. This is a possible future study of great interest especially 
for insurance providers. 
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10 SAMMANFATTNING PÅ SVENSKA 
Den moderna höftprotesen introducerades på 1960-talet av Sir John Charnley och har 
sedan dess varit en framgångsrik metod att kirurgiskt behandla smärtsamma 
höftsjukdomar och skador. I Sverige genomförs årligen ca 16 000 
höftprotesoperationer. Proteserna har genom åren utvecklats genom bland annat 
förbättrad fixation till skelettet och genom material med mindre slitage. Eftersom 
protesrelaterade komplikationer är ovanliga och ofta sker flera år efter operationen är 
det bästa sättet att studera dem genom observationella studier på stora patientgrupper 
under lång tid. Tack vare höftprotesregister har man tidigt kunnat identifiera dåliga 
protesmodeller och därigenom hitta de modeller som har bäst långtidsresultat. Utfallet 
av en höftprotesoperation kan bedömas utifrån patientens förbättrade livskvalitet och 
minskad smärta och utifrån förekomst av komplikation med eller utan behov av 
omoperation.  
 
Denna avhandling innefattar 2 olika aspekter av komplikationer efter 
höftprotesoperation. De första två studierna behandlar det kirurgiska snittets inverkan 
på risken av att behöva byta ut protesen och på patientrapporterat utfall. De 3 sista 
arbetena studerar olika aspekter av djup infektion efter höftprotesoperation. 
Registerdata utgör grunden för samtliga studier. 
Studie 1 är en kohortstudie med data från Svenska Höftprotesregistret (SHPR) av 
patienter som opererats med en primär cementerad total höftledsprotes av de 3 vanligast 
förekommande fabrikaten. Utfallet är risk för revision (byte av en eller flera 
protesdelar) och jämför de två mest använda kirurgiska snitten till höftleden. Studien 
inkluderar 90 662 patienter primärt opererade 1992-2009. Resultaten visar att ett bakre 
snitt associeras med ökad risk för revision av protesen på grund av luxation men med 
mindre risk för revision på grund av lossning jämfört med ett lateralt snitt, men att detta 
också skiljde sig åt mellan protesfabrikaten. 
Studie 2 är en kohortstudie av patienter opererade med en total höftledsprotes på grund 
av artros och jämför snittets inverkan på patientrapporterat utfall såsom det registreras i 
SHPR. Den innefattar 42 233 patienter opererade mellan 2002-2010. Den visar att ett 
bakre snitt leder till ett något bättre utfall avseende smärta, nöjdhetsgrad och 
hälsorelaterad livskvalitet jämfört med ett lateralt snitt. Skillnaderna stod sig upp till 6 
år efter primäroperationen.   
Studie 3 och 4 är deskriptiva studier som studerar incidensen av djup protesinfektion 
inom 2 år efter primär höftledsprotesoperation. De innefattar 45 531 patienter med 
49 419 höftledsproteser registrerade i SHPR. Dessa patienter matchades med 
läkemedelsregistret avseende förskriven antibiotika efter operationen. I en efterföljande 
journalstudie av de 2 219 patienter som haft minst 1 månads sammanhängande 
antibiotikabehandling inom 2 år efter operationen kunde incidensen av djup 
protesinfektion bestämmas till 0,9 % vilket presenteras i Studie 3. I Studie 4 jämfördes 
de identifierade omoperationerna i studien med SHPRs omoperationsdatabas och 
visade att en tredjedel av antalet omoperationer inte var registrerade. 
Studie 5 är en fall-kontrollstudie som jämför olika faktorers inverkan på risken att 
drabbas av protesinfektion. Den innefattar de 194 patienter opererade under 2008 som 
postoperativt drabbats av infektion. Dessa jämförs med 4 matchade kontroller per fall 
och visar att patientens samsjuklighet spelar större roll för infektionsrisken än 
operations- och omgivningsfaktorer.  
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Sammanfattningsvis visar denna avhandling att det kirurgiska snittet påverkar utfallet 
efter en höftprotesoperation på olika sätt varför detta är en faktor att ta i beaktande vid 
planering av en operation. Avhandlingen beskriver en ny metod att bestämma 
incidensen av infektion efter höftprotesoperation och att SHPRs omoperationsdatabas 
inte med säkerhet kan användas för att följa incidensen av djup protesinfektion. Den 
visar att samsjuklighet spelar större roll än operations- och omgivningsfaktorer för 
risken att drabbas av en infektion, vilket försvårar förbättringsarbetet. 
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13 APPENDIX 
  Relative Risk 95 % CI p-value 
Dislocation     
Age (years) <50  0.5 0.2-1.3 0.2 
 50-59 0.9 0.6-1.3 0.5 
 60-75 0.9 0.7-1.1 0.3 
 >75 1   
Sex Female 1   
 Male 1.2 1.0-1.5 0.03 
Order 1st hip 1.0 0.8-1.3 0.9 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 3.2 2.6-4.0 <0.001 
 Other 1.5 1.0-2.1 0.03 
Cup FAL 1.7 1.3-2.4 <0.001 
 Lubinus All-Poly 1   
Head Ceramics 0.7 0.5-1.0 0.06 
 Co-Cr 1   
Surgical approach Lateral 0.7 0.5-0.8 0.001 
 Posterior 1   
Side Left 1   
 Right 1.0 0.8-1.2 0.8 
Loosening     
Age (years) <50  8.4 5.4-13.0 <0.001 
 50-59 6.0 4.3-8.3 <0.001 
 60-75 3.0 2.2-4.0 <0.001 
 >75 1   
Sex Female 1   
 Male 2.1 1.8-2.5 <0.001 
Order 1st hip 1.0 0.8-1.3 1.0 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 1.3 0.9-1.8 0.1 
 Other 1.2 0.9-1.6 0.2 
Cup FAL 0.5 0.3-1.0 0.05 
 Lubinus All-Poly 1   
Head Ceramics 0.5 0.3-0.7 <0.001 
 Co-Cr 1   
Surgical approach Lateral 1.3 1.0-1.6 0.02 
 Posterior 1   
Side Left 1   
 Right 1.2 1.0-1.4 0.03 
Infection     
Age (years) <50  1.9 1.0-3.7 0.07 
 50-59 1.1 0.7-1.7 0.7 
 60-75 0.9 0.7-1.2 0.7 
 >75 1   
Sex Female 1   
 Male 2.2 1.7-2.7 <0.001 
Order 1st hip 0.7 0.6-1.0 0.04 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 1.8 1.3-2.6 <0.001 
 Other 1.6 1.1-2.4 0.03 
Cup FAL 0.7 0.4-1.1 0.1 
 Lubinus All-Poly 1   
Head Ceramics 0.7 0.5-1.1 0.09 
 Co-Cr 1   
Surgical approach Lateral 0.9 0.70-1.2 0.6  
 Posterior 1   
Side Left 1   
 Right 1.2 0.9-1.5 0.2 
 
Table 9. Relative risks of revision for the Lubinus SPII (Cox regression). Parameters with value 1 are 
reference. 
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 Dislocation Loosening 
 Lateral Posterior Lateral Posterior 
 n % n % n % N % 
Stem 2 3 13 4 28 24 93 20 
Stem + 
Cup 11 14 20 5 50 43 231 49 
Cup 37 47 137 37 34 29 139 30 
Extraction 1 1 14 4 3 3 6 1 
Other 28 35 186 50 1 1 1 0 
         
Total 79 100 370 100 116 100 470 100 
 
Table 10. Components exchanged or removed due to dislocation or loosening of the Lubinus SPII 
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  Relative Risk 95 % CI p-value 
Dislocation     
Age (years) <50  0.7 0.3-2.0 0.5 
 50-59 0.9 0.5-1.6 0.8 
 60-75 1.1 0.8-1.5 0.7 
 >75 1   
Sex Female 1   
 Male 1.3 1.0-1.8 0.08 
Order 1st hip 0.9 0.6-1.3 0.6 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 3.4 2.2-5.1 <0.001 
 Other 2.0 1.2-3.3 0.01 
Cup 
Contemporary 
Hooded Duration 1   
 Exeter All-Poly 0.7 0.4-1.4 0.3 
 Exeter Duration 0.9 0.5-1.5 0.6 
Surgical approach Lateral 0.6 0.3-1.1 0.1 
 Posterior 1   
Side Right 1.0 0.7-1.3 0.7 
 Left 1   
Loosening     
Age (years) <50  6.0 3.8-9.6 <0.001 
 50-59 3.8 2.5-5.6 <0.001 
 60-75 2.2 1.6-3.2 <0.001 
 >75 1   
Sex Female 1   
 Male 0.8 0.8-1.2 0.8 
Order 1st hip 1.0 0.7-1.3 0.9 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 0.6 0.4-1.1 0.09 
 Other 1.2 0.9-1.7 0.2 
Cup 
Contemporary 
HoodedDuration 1   
 Exeter All-Poly 2.5 1.3-5.7 0.01 
 Exeter Duration 0.9 0.5-1.8 0.9 
Surgical approach Lateral 0.9 0.5-1.5 0.6 
 Posterior 1   
Side Right 1.1 0.9-1.3 0.6 
 Left 1   
Infection     
Age (years) <50  1.5 0.4-5.0 0.6 
 50-59 1.1 0.7-2.9 0.3 
 60-75 1.3 0.8-2.1 0.4 
 >75 1   
Sex Female 1   
 Male 2.2 1.4-3.4 <0.001 
Order 1st hip 0.6 0.4-1.1 0.09 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 4.3 2.5-7.5 <0.001 
 Other 1.2 0.6-2.8 0.6 
Cup 
Contemporary 
Hooded Duration 1   
 Exeter All-Poly 0.6 0.3-1.5 0.3 
 Exeter Duration 1.3 0.6-2.6 0.5 
Surgical approach Lateral 1.1 0.6-2.3 0.7  
 Posterior 1   
Side Right 1.1 0.8-1.7 0.6 
 Left 1   
 
Table 11. Relative risks of revision for the Exeter prosthesis (Cox regression). Parameters with value 1 
are reference 
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 Dislocation Loosening 
 Lateral Posterior Lateral Posterior 
 n  % n % n % N % 
Stem 5 31 32 22 0 0 26 8 
Stem + 
Cup 0 0 27 18 9 45 102 32 
Cup 8 50 56 38 11 55 190 59 
Extraction 0 0 4 3 0 0 4 1 
Other 3 19 28 19     
         
Total 16 100 147 100 20 100 322 100 
 
Table 12. Components exchanged or removed due to dislocation or loosening of the Exeter 
prosthesis 
 
 
  Relative Risk 95 % CI p-value 
Dislocation     
Age (years) < 60 0.7 0.2-3.1 0.6 
 60-75 1.2 0.6-2.1 0.7 
 > 75 1   
Sex Female 1   
 Male 1.0 0.5-1.9 1.0 
Order 1st hip 1.6 0.6-4.5 0.4 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 4.8 2.5-9.0 <0.001 
 Other 1.4 0.4-4.9 0.6 
Surgical approach Lateral 0.2 0.1-0.4 <0.001 
 Posterior 1   
Side Right 1.0 0.5-1.8 1.0 
 Left 1   
Loosening     
Age (years) < 60 7.1 3.8-13.2 <0.001 
 60-75 2.9 1.7-4.8 <0.001 
 > 75 1   
Sex Female 1   
 Male 1.3 0.9-1.8 0.2 
Order 1st hip 0.7 0.5-1.1 0.2 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 0.8 0.5-1.6 0.6 
 Other 1.1 0.6-2.1 0.7 
Surgical approach Lateral 1.6 1.0-2.5 0.04 
 Posterior 1   
Side Right 1.1 0.8-1.5 0.7 
 Left 1   
Infection     
Age (years) < 60 1.9 0.7-5.1 0.2 
 60-75 1.2 0.6-2.4 0.6 
 > 75 1   
Sex Female 1   
 Male 2.9 1.6-5.5 0.001 
Order 1st hip 0.8 0.4-1.6 0.4 
 2nd hip 1   
Diagnosis Osteoarthritis 1   
 Fracture 1.5 0.6-3.6 0.4 
 Other 2.5 1.1-6.0 0.04 
Surgical approach Lateral 0.9 0.5-1.8 0.8 
 Posterior 1   
Side Right 0.9 0.5-1.6 0.7 
 Left 1   
 
Table 13. Relative risks of revision for the Spectron prosthesis (Cox regression). Parameters with 
value 1 are reference. 
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 Dislocation Loosening 
 Lateral Posterior Lateral Posterior 
 n % n % n % n % 
Stem 1 6 0 0 13 13 3 11 
Stem + 
Cup 4 22 1 4 32 33 9 33 
Cup 9 50 18 69 48 50 13 48 
Extraction 2 11 1 4 4 4 2 7 
Other 2 11 6 23     
         
Total 18 100 26 100 97 100 27 101 
 
Table 14. Components exchanged or removed due to dislocation or loosening of the Spectron EF 
Primary prosthesis 
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Antibiotic ATC-code Daily dose 
4 weeks 
treatment 
Amoxicillin  J01CA04  750 mg 1x3  84 
Amoxicillin and clavulanic acid J01CR02 875/125 mg 1x2 56 
Azitromycin J01FA10 250 mg 1x1 28 
Cefadroxil J01DB05 1 g 1x2 56 
Cefalexin J01DB01 3 g 1x2 56 
Ceftriaxon J01DD04 2 g 1x1 28 
Ceftributen J01DD14 400 mg 1x1 28 
Cefuroxim J01DC02 250 mg 1x2 56 
Ciprofloxacin  J01MA02 250 mg 1x2 56 
  500 mg 1x2 56 
  750 mg 1x2  56 
Daptomycin  J01XX09 400 mg 1x1 28 
Ertapenem J01DH03 1 g 1x2 28 
Erytromycin J01FA01 250 mg 2x2 112 
Fenoximetylpenicillin J01CE02  1 g 2x3 168 
Flukloxacillin  J01CF05  500 mg 2x3  168 
  750 mg 2x3  168 
Fusidic acid J01XC01 250 mg 2x3  168 
Klaritromycin J01FA09 250 mg 1x2 56 
Klindamycin  J01FF01  300 mg 1x2  56 
Levofloxacin J01MA12 500 mg 1x1 28 
Linezolid  J01XX08 600 mg 1x2  56 
Lorakarbef J01DC08 200 mg 1x2 56 
Metronidazole P01AB01  400 mg 1x3  84 
Moxifloxacin J01MA14 400 mg 1x1 28 
Norfloxacin J01MA06 400 mg 1x2 56 
Rifampicin  J04AB02 600 mg 1x1 28 
Roxitromycin J01FA06 150 mg 1x2 56 
Sulfametoxazol and trimetoprim  J01EE01  160 mg/800 mg 1x2 56 
Teikoplanin  J01XA02 400 mg 1x1 28 
Telitromycin J01FA15 400 mg 2x1 56 
Vancomycin  J01XA01 1 g 1x2 56 
 
Table 15. Number of tablets/doses required for 4 weeks of continuous treatment.  
(ATC-code = Anatomic Therapeutic Chemical-code) 
 
 
